Proton versus photon therapy for esophageal cancer – A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer
Research output: Contribution to journal › Editorial (Lead article) › Contributed › peer-review
Contributors
- Aarhus University
- KU Leuven
- University of Leeds
- University of Groningen
- University College London
- Maastricht University Medical Centre (UMC+)
- Paul Scherrer Institute
- University of Zurich
- University of Sydney
- University of Copenhagen
- Oxford University Hospitals NHS Foundation Trust
- University of Oxford
- The Christie NHS Foundation Trust
- Maastricht University
- Provincial Health Services Company Trento
- CNAO National Center for Oncological Hadrontherapy
- Centre Antoine Lacassagne
- Centre Léon Bérard
- Institut Curie
- University Medical Center Groningen
- The University of Auckland
- Erasmus University Rotterdam
Details
| Original language | English |
|---|---|
| Article number | 109980 |
| Journal | Radiotherapy and oncology |
| Volume | 190 |
| Publication status | Published - Jan 2024 |
| Peer-reviewed | Yes |
External IDs
| PubMed | 37935284 |
|---|